CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 2,562 shares at $1.63 ($4,176)
- 4 Open-market buy Chief Financial Officer bought 39,000 shares at $0.29 ($11,326)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Operating Officer sold 4,368 shares at $3.19 ($13,942)
- 4 Open-market sale Chief Patient Supply Officer sold 4,368 shares at $3.19 ($13,942)
- 4 Open-market sale Chief Medical Officer sold 2,121 shares at $3.19 ($6,770)
- 4 Open-market sale Chief Executive Officer sold 11,096 shares at $3.19 ($35,416)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Operating Officer sold 6,018 shares at an average $3.55 ($21,376)
- 4 Open-market sale Chief Patient Supply Officer sold 4,846 shares at an average $3.55 ($17,222)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 4,624 shares at an average $3.55 ($16,435)
- 4 Open-market sale Chief Executive Officer sold 17,408 shares at an average $3.55 ($61,877)
- 4 Derivatives Options or other derivatives
Page 6 of 18 · 351 filings